|
What we know about rehabilitation in Parkinson Disease and what need to know both clinical practice and scientific research to improve patients’ care| old_uid | 10617 |
|---|
| title | What we know about rehabilitation in Parkinson Disease and what need to know both clinical practice and scientific research to improve patients’ care |
|---|
| start_date | 2016/01/28 |
|---|
| schedule | 10h30-12h |
|---|
| online | no |
|---|
| location_info | EuroMov |
|---|
| summary | Parkinson disease is often beginning in the sixth or seventh decade of life, and it is characterized by the unilateral onset of resting tremor in combination with varying degrees of rigidity and bradykinesia. Parkinson disease ranks among the most common late-life neurodegenerative diseases, affecting approximately 1.5% to 2.0% of people aged 60 and older. Although medical (Levodopa and dopamine agonist) and surgical treatments have transformed the issue of the disease, many symptoms (postural, cognitive, emotional, vegetative &) remain and alter mobility and quality of life of the patients. Rehabilitation with physiotherapy, speech therapy and occupational therapy are an interesting approach of the disease because of the complementarities with medical and surgical treatments. Improvements in gait, balance, endurance and quality of life have been demonstrated in previous studies. This will be developed in the presentation. Given the aging population, and subsequent increase in the prevalence of the disease, increased focus must move towards addressing the organization of health care in the society. New concepts as auto rehabilitation programs, new technologies (as Beat Health &:), and group sessions (with Tango or Tai Chi for example) are growing opportunities to help patients to perform activities and maintain their capacities and social participation. Clinical studies explore global benefits of these practices for experimental groups of patients but neuronal mechanisms, psycho cognitive aspects, and individualized indications remain often ignored. The purpose of this presentation is to explore scientific literature to take an inventory of the needs both for the clinician practice and the scientific research in order to improve patients with Parkinson disease’s care. |
|---|
| responsibles | Hoffmann, Marin |
|---|
| |
|